Blood Group Genotyping for Sickle Cell and Thalassaemi

Award

Buyers

NHS England, Leeds

Value

£140,671

Suppliers

NHS Blood and Transplant (NHSBT)

Classifications

Blood analysis services

Tags

award

Submission Deadline

5 months ago

Published

1 month ago

Description

The main output of this programme is for blood group genotyping to become embedded into routine practice. Primary objective (benefit) of doing so is to ensure patients with rare blood disorders have a minimise risk of adverse reactions through access to blood group genotyping.

Documents

Premium

Bypass the hassle of outdated portals. Get all the information you need right here, right now.

Contract Agreement

The official contract terms, conditions, and scopes of work.

Download
Award Notice

Details on the tender award and selected suppliers.

Download

Similar Contracts

Open

Sample Analysis (Snake Venom)

The purpose of this project is to evaluate efficacy and safety of a range of existing and new antivenoms with, developing evidence for policy-makers on the optimum antivenoms for their countries. This tender will cover the analysis of the clinical samples collected during the ANYSNAKES trial. In addition to this a subset of samples will be part of our trial looking at small molecule which can inhibit venom (TOCSINS). This procurement is intended to establish a supplier relationship that can support the initial study described, as well as future studies of a similar nature that may arise during the contract period. Each additional study will be confirmed through an agreed task order or variation. For more information about this opportunity, please visit the Delta eSourcing portal at: https://www.delta-esourcing.com/tenders/UK-UK-Liverpool:-Analysis-services./269MYMDB2N To respond to this opportunity, please click here: https://www.delta-esourcing.com/respond/269MYMDB2N

Published 1 week ago

Open

BADGER FOUND DEAD AND ANY OTHER WILDLIFE SPECIES C179/2025/2026

The Client wishes to procure a 2 year with an optional extension period of an additional one plus one year to be determined by the client (a maximum contract period of 4 years including the optional extension period), for the Badger Found Dead and any other Wildlife Species Contract. The value of the Contract is expected within the range of £750,000-£880,000 excluding VAT for the entire 4 year period. The successful Bidder must provide a fully managed service delivery to undertake all activities relating to this Contract- Collect, arrange transportation and undertake a post mortem of badgers found dead and other wildlife species as required. The Bidder must also promote this service to the public and the farming industry throughout the contract duration. The aim and objective of this service is to provide information on the prevalence of Mycobacterium bovis (M.bovis) infection in badgers by means of a post mortem examination and submission of samples for culture, molecular typing and histological examination. This data and analysis will provide vital information on the prevalence of (M bovis) infection in badgers and on genotypes present. The results of the contract will be used to investigate the relationship between (M.bovis) infection in badgers and cattle and will assist in the formulation of policy at both local and national levels. It will also add to epidemiological reporting and provide evidence to case vets.

Published 2 weeks ago

Open

Toxicology Services - Drug and Alcohol Testing

The GPhC wishes to inform the market of our intention to procure the provision of Toxicology Services - Drug and Alcohol Testing. Where there are concerns regarding physical or mental health, specifically drug and alcohol misuse, the GPhC may necessitate a Pharmacy Registrant (donor) undergo medical assessment, forming part of a wider Fitness to Practise investigation. In such cases, Toxicology Services (drug and alcohol testing) will be required to ascertain: i. if substance(s), as specified by the GPhC, have been used by the donor. ii. if substance(s), as specified by the GPhC, are being used by the donor. Moreover, a Registrant may also be required to enter a period of 'medical supervision' - monitoring to confirm compliance with any restrictions on their registration. Here, Toxicology Services (drug and alcohol testing) will be required to verify fulfilment of conditions set. The purpose of this notice is to raise awareness of our upcoming Request for Quotation sourcing activity, gauge accurate levels of market interest, and receive feedback on prospective plans/requirements in advance of the formal procurement process; to be announced in October 2025. Scope of services will include, the: 1. Supply of Phlebotomists and Specimen Collectors -throughout Great Britain- to collect donor samples: hair (head and body), nail, saliva, blood and urine. 2. Undertaking of sample drug testing for, but not limited to amphetamines, benzodiazepines, cannabinoids, cocaine, hallucinogens, hypnotic substances, ketamine, mephedrone, methadone, methamphetamines (including MDMA and MDEA), novel psychoactive substances, opiates, opioids, sedatives, steroids and tramadol. 3. Undertaking of sample alcohol -ethanol- testing; including phosphatidyl ethanol (PEth), carbohydrate-deficient transferrin (CDT) and fatty acid ethyl esters (FAEE) biomarkers, and ethyl glucuronide (EtG). 4. Undertaking of liver blood testing, formerly known as liver function tests (LFT). 5. Undertaking of full blood count testing (FBC), including mean corpuscular volume testing (MCV). 6. Secure email provision of sample analysis results within 3 working days; including the provision of supplementary reports which interpret results in an accessible (free from technical jargon, where possible), clear and concise manner. 7. Provision of a Certificate of Analysis (CoA). 8. Provision of testimony in the capacity of an Independent Expert Witness (where donor samples are tested for legal purposes). N.B. the Service Provider remains responsible for ensuring staff are adequately trained to undertake this requirement, if requested. Please note, samples are to be collected at a donors' home residence, or a neutral site as determined by the Service Provider. We kindly ask that all interested suppliers complete and submit this response form to Anna Kitoki, at [email protected] by 17:00 on 02.09.2025. Any interest shown does not constitute a commitment to participate; and failure to show interest does not restrict suppliers from participating in this and/or any other procurement process run by the GPhC.

Published 1 month ago

AI Bid Assistant

Our AI-powered tool to help you create winning bids is coming soon!

View Contract Source Save Contract

Organisation

NHS England, Leeds

Pratim Saikia

[email protected]

Timeline complete

Publish

Bid

Evaluate

Award

Complete